$SNSS Recent News Ken Griffin has loaded up on
Post# of 102233
Posted On: 01/06/2015 1:27:44 PM
$SNSS Recent News
Ken Griffin has loaded up on Angie's List 11:04 a.m. Oct. 24, 2014 - Insider Monkey
United Rentals, Best Buy, GM lead the way lower 3:25 p.m. Oct. 7, 2014 - Ben Eisen
U.S. stocks end volatile session lower 3:31 p.m. Oct. 6, 2014 - Anora Mahmudova
H-P rallies on corporate split; H&R Block sinks 8:18 a.m. Oct. 6, 2014 - Ben Eisen
A one-day fling for stocks, and fret more over gold than over the dollar 7:41 a.m. Oct. 6, 2014 - Barbara Kollmeyer
Sunesis Pharma shares crater after failed cancer drug trial 6:42 a.m. Oct. 6, 2014 - Ciara Linnane
Sunesis Pharma shares crater 60% in premarket trade 6:32 a.m. Oct. 6, 2014 - Ciara Linnane
Sunesis Pharma says cancer drug railed in late-stage trial 6:32 a.m. Oct. 6, 2014 - Ciara Linnane
Stocks to Watch Friday: Analogic, Werner 3:36 p.m. Sept. 13, 2012 - David B. Wilkerson
Thursday’s biggest gaining and declining stocks 2:39 p.m. Sept. 13, 2012 - MarketWatch
Stocks to Watch Wednesday: Texas Instruments 4:25 p.m. Sept. 11, 2012 - David B. Wilkerson
Tuesday’s top gaining and declining stocks 3:57 p.m. Sept. 11, 2012 - MarketWatch
Sunesis Pharma up 57% in premarket 7:46 a.m. Sept. 11, 2012 - Steve Gelsi
ASCO studies shake up drug stocks 3:17 p.m. June 7, 2011 - Val Brickates Kennedy
Exelixis, Sunesis lead drug stocks lower 2:42 p.m. June 6, 2011 - Val Brickates Kennedy
Sunesis tumbles 16% in early trading 9:27 a.m. June 6, 2011 - Val Brickates Kennedy
The 7 Most Important Drug-Stock Lessons From This Weekend's Blood Cancer Meeting 7:15 a.m. Dec. 8, 2014 - TheStreet.com
Sunesis Spin Doctor Tiptoes Around Failed Leukemia Drug Trial 5:28 p.m. Dec. 7, 2014 - TheStreet.com
Five Biotech Firms Whose Stock-Promoting Efforts Didn't Pay Off 11:00 a.m. Dec. 2, 2014 - TheStreet.com
Today In SA PRO: Monday, December 1 5:00 a.m. Dec. 2, 2014 - Seeking Alpha
Announcing This Week's Outstanding Performance Award Winners - New Capital And EnhydrisPECorp 5:00 a.m. Dec. 1, 2014 - Seeking Alpha
Sunesis Pharmaceuticals (SNSS) Jumps: Stock Surges 38.3% - Tale of the Tape 9:25 a.m. Nov. 18, 2014 - Zacks.com
Sunesis Pharmaceuticals Bounces On Results Announcement 1:51 p.m. Nov. 17, 2014 - TheStreet.com
Sunesis Pharmaceuticals (SNSS) Stock Surges on Upcoming Announcement of Blood Cancer Treatment Data 11:54 a.m. Nov. 17, 2014 - TheStreet.com
Sunesis Pharma tries to regain some of last month's plunge 11:40 a.m. Nov. 17, 2014 - Seeking Alpha
Sunesis Pharmaceuticals' (SNSS) CEO Daniel Swisher on Q3 2014 Results - Earnings Call Transcript 3:15 p.m. Nov. 10, 2014 - Seeking Alpha
Sunesis Pharmaceuticals (SNSS) Q3 2014 Results - Earnings Call Webcast 10:25 a.m. Nov. 10, 2014 - Seeking Alpha
3 Biotech Stocks for Earnings Beats this Season - Earnings ESP 1:38 p.m. Nov. 5, 2014 - Zacks.com
3 Biotech Stocks for Earnings Beats this Season - Earnings ESP 1:38 p.m. Nov. 5, 2014 - Zacks.com
Which Stocks Hurt Billionaire Portfolios the Most in 2014? 7:48 a.m. Oct. 27, 2014 - TheStreet.com
Sunesis Pharmaceuticals (SNSS) Jumps: Stock Gains 8.5% - Tale of the Tape 8:46 a.m. Oct. 15, 2014 - Zacks.com
Sunesis Pharmaceuticals, Inc. Craters On Negative VALOR Data. Stock Is Now A Terminal Short 8:19 a.m. Oct. 8, 2014 - Seeking Alpha
Biotech Stock Roundup: Sunesis Tanks on Study Results, Chimerix Up on Ebola Update - Analyst Blog 7:14 a.m. Oct. 8, 2014 - Zacks.com
Sunesis Pharmaceuticals Down on Failure of Trial on Qinprezo - Analyst Blog 3:40 p.m. Oct. 7, 2014 - Zacks.com
It's True, Small-Cap Biotech Stocks Are Acting Badly These Days 10:39 a.m. Oct. 7, 2014 - TheStreet.com
Why Sunesis Pharmaceuticals (SNSS) Stock Hit a One-Year Low Today 10:31 a.m. Oct. 6, 2014 - TheStreet.com
Biotech Stocks Technical Report -- Achillion Pharma, Arrowhead Research, Sunesis Pharma, Array BioPharma, and Seattle Genetics 9:10 a.m. Dec. 22, 2014 - PR Newswire - PRF
Sunesis Announces Presentation of Positive Updated Results from Ongoing MD Anderson-Sponsored Trial of Vosaroxin in AML and High-Risk MDS at ASH Annual Meeting 1:31 p.m. Dec. 8, 2014 - GlobeNewswire
Sunesis Pharmaceuticals Announces Presentation of Results From Phase 3 VALOR Trial at ASH Annual Meeting 12:31 p.m. Dec. 7, 2014 - GlobeNewswire
Sunesis Announces Publication of Vosaroxin Phase 1b/2 AML Trial Results in Haematologica 7:00 a.m. Nov. 19, 2014 - GlobeNewswire
Sunesis Pharmaceuticals Announces Late-Breaking Presentation of Phase 3 VALOR Trial at ASH Annual Meeting 9:06 a.m. Nov. 17, 2014 - GlobeNewswire
Biotech Equities Technical Coverage - Orexigen Therapeutics, Novavax, Sunesis Pharma, Celldex Therapeutics, and Navidea Biopharma 8:45 a.m. Nov. 17, 2014 - PR Newswire - PRF
Sunesis Pharmaceuticals Reports Third Quarter 2014 Financial Results and Recent Highlights 7:02 a.m. Nov. 10, 2014 - GlobeNewswire
Sunesis to Host Conference Call on November 10th to Discuss Third Quarter 2014 Financial Results and Recent Highlights 7:01 a.m. Nov. 3, 2014 - GlobeNewswire
Pre-market Biotech Picks - Gilead Sciences, MannKind, IsoRay, Orexigen Therapeutics, and Sunesis Pharma 8:00 a.m. Oct. 14, 2014 - PR Newswire - PRF
Sunesis Announces Results From Pivotal Phase 3 VALOR Trial of Vosaroxin and Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia 5:30 a.m. Oct. 6, 2014 - GlobeNewswire
Biotech Stocks Under Review -- Keryx Biopharma, Sangamo BioSciences, Regeneron Pharma, Sunesis Pharma, and Idera Pharma 8:10 a.m. Sept. 9, 2014 - PR Newswire - PRF
Sunesis to Present at the 2014 Morgan Stanley Global Healthcare Conference 6:01 a.m. Sept. 4, 2014 - GlobeNewswire
Sunesis to Present at the 2014 Wedbush Life Sciences Management Access Conference 6:01 a.m. Aug. 6, 2014 - GlobeNewswire
Sunesis Pharmaceuticals Reports Second Quarter 2014 Financial Results and Recent Highlights 6:02 a.m. Aug. 5, 2014 - GlobeNewswire
Sunesis to Host Conference Call on August 5th to Discuss Second Quarter 2014 Financial Results and Recent Highlights 6:01 a.m. July 29, 2014 - GlobeNewswire
Sunesis Pharmaceuticals Announces European Medicines Agency Acceptance of Pediatric Investigation Plan for Qinprezo(TM) (Vosaroxin) for AML 6:00 a.m. July 9, 2014 - GlobeNewswire
Sunesis to Present at the 2014 Wells Fargo Healthcare Conference 6:01 a.m. June 11, 2014 - GlobeNewswire
Sunesis Announces Presentation of Positive Updated Results From Ongoing MD Anderson-Sponsored Trial of Vosaroxin in AML and High-Risk MDS at ASCO 2014 Annual Meeting 6:01 a.m. June 2, 2014 - GlobeNewswire
Sunesis to Present at Upcoming Investor Conferences 6:02 a.m. May 14, 2014 - GlobeNewswire
Sunesis Pharmaceuticals Reports First Quarter 2014 Financial Results and Recent Highlights 6:01 a.m. May 7, 2014 - GlobeNewswire
Ken Griffin has loaded up on Angie's List 11:04 a.m. Oct. 24, 2014 - Insider Monkey
United Rentals, Best Buy, GM lead the way lower 3:25 p.m. Oct. 7, 2014 - Ben Eisen
U.S. stocks end volatile session lower 3:31 p.m. Oct. 6, 2014 - Anora Mahmudova
H-P rallies on corporate split; H&R Block sinks 8:18 a.m. Oct. 6, 2014 - Ben Eisen
A one-day fling for stocks, and fret more over gold than over the dollar 7:41 a.m. Oct. 6, 2014 - Barbara Kollmeyer
Sunesis Pharma shares crater after failed cancer drug trial 6:42 a.m. Oct. 6, 2014 - Ciara Linnane
Sunesis Pharma shares crater 60% in premarket trade 6:32 a.m. Oct. 6, 2014 - Ciara Linnane
Sunesis Pharma says cancer drug railed in late-stage trial 6:32 a.m. Oct. 6, 2014 - Ciara Linnane
Stocks to Watch Friday: Analogic, Werner 3:36 p.m. Sept. 13, 2012 - David B. Wilkerson
Thursday’s biggest gaining and declining stocks 2:39 p.m. Sept. 13, 2012 - MarketWatch
Stocks to Watch Wednesday: Texas Instruments 4:25 p.m. Sept. 11, 2012 - David B. Wilkerson
Tuesday’s top gaining and declining stocks 3:57 p.m. Sept. 11, 2012 - MarketWatch
Sunesis Pharma up 57% in premarket 7:46 a.m. Sept. 11, 2012 - Steve Gelsi
ASCO studies shake up drug stocks 3:17 p.m. June 7, 2011 - Val Brickates Kennedy
Exelixis, Sunesis lead drug stocks lower 2:42 p.m. June 6, 2011 - Val Brickates Kennedy
Sunesis tumbles 16% in early trading 9:27 a.m. June 6, 2011 - Val Brickates Kennedy
The 7 Most Important Drug-Stock Lessons From This Weekend's Blood Cancer Meeting 7:15 a.m. Dec. 8, 2014 - TheStreet.com
Sunesis Spin Doctor Tiptoes Around Failed Leukemia Drug Trial 5:28 p.m. Dec. 7, 2014 - TheStreet.com
Five Biotech Firms Whose Stock-Promoting Efforts Didn't Pay Off 11:00 a.m. Dec. 2, 2014 - TheStreet.com
Today In SA PRO: Monday, December 1 5:00 a.m. Dec. 2, 2014 - Seeking Alpha
Announcing This Week's Outstanding Performance Award Winners - New Capital And EnhydrisPECorp 5:00 a.m. Dec. 1, 2014 - Seeking Alpha
Sunesis Pharmaceuticals (SNSS) Jumps: Stock Surges 38.3% - Tale of the Tape 9:25 a.m. Nov. 18, 2014 - Zacks.com
Sunesis Pharmaceuticals Bounces On Results Announcement 1:51 p.m. Nov. 17, 2014 - TheStreet.com
Sunesis Pharmaceuticals (SNSS) Stock Surges on Upcoming Announcement of Blood Cancer Treatment Data 11:54 a.m. Nov. 17, 2014 - TheStreet.com
Sunesis Pharma tries to regain some of last month's plunge 11:40 a.m. Nov. 17, 2014 - Seeking Alpha
Sunesis Pharmaceuticals' (SNSS) CEO Daniel Swisher on Q3 2014 Results - Earnings Call Transcript 3:15 p.m. Nov. 10, 2014 - Seeking Alpha
Sunesis Pharmaceuticals (SNSS) Q3 2014 Results - Earnings Call Webcast 10:25 a.m. Nov. 10, 2014 - Seeking Alpha
3 Biotech Stocks for Earnings Beats this Season - Earnings ESP 1:38 p.m. Nov. 5, 2014 - Zacks.com
3 Biotech Stocks for Earnings Beats this Season - Earnings ESP 1:38 p.m. Nov. 5, 2014 - Zacks.com
Which Stocks Hurt Billionaire Portfolios the Most in 2014? 7:48 a.m. Oct. 27, 2014 - TheStreet.com
Sunesis Pharmaceuticals (SNSS) Jumps: Stock Gains 8.5% - Tale of the Tape 8:46 a.m. Oct. 15, 2014 - Zacks.com
Sunesis Pharmaceuticals, Inc. Craters On Negative VALOR Data. Stock Is Now A Terminal Short 8:19 a.m. Oct. 8, 2014 - Seeking Alpha
Biotech Stock Roundup: Sunesis Tanks on Study Results, Chimerix Up on Ebola Update - Analyst Blog 7:14 a.m. Oct. 8, 2014 - Zacks.com
Sunesis Pharmaceuticals Down on Failure of Trial on Qinprezo - Analyst Blog 3:40 p.m. Oct. 7, 2014 - Zacks.com
It's True, Small-Cap Biotech Stocks Are Acting Badly These Days 10:39 a.m. Oct. 7, 2014 - TheStreet.com
Why Sunesis Pharmaceuticals (SNSS) Stock Hit a One-Year Low Today 10:31 a.m. Oct. 6, 2014 - TheStreet.com
Biotech Stocks Technical Report -- Achillion Pharma, Arrowhead Research, Sunesis Pharma, Array BioPharma, and Seattle Genetics 9:10 a.m. Dec. 22, 2014 - PR Newswire - PRF
Sunesis Announces Presentation of Positive Updated Results from Ongoing MD Anderson-Sponsored Trial of Vosaroxin in AML and High-Risk MDS at ASH Annual Meeting 1:31 p.m. Dec. 8, 2014 - GlobeNewswire
Sunesis Pharmaceuticals Announces Presentation of Results From Phase 3 VALOR Trial at ASH Annual Meeting 12:31 p.m. Dec. 7, 2014 - GlobeNewswire
Sunesis Announces Publication of Vosaroxin Phase 1b/2 AML Trial Results in Haematologica 7:00 a.m. Nov. 19, 2014 - GlobeNewswire
Sunesis Pharmaceuticals Announces Late-Breaking Presentation of Phase 3 VALOR Trial at ASH Annual Meeting 9:06 a.m. Nov. 17, 2014 - GlobeNewswire
Biotech Equities Technical Coverage - Orexigen Therapeutics, Novavax, Sunesis Pharma, Celldex Therapeutics, and Navidea Biopharma 8:45 a.m. Nov. 17, 2014 - PR Newswire - PRF
Sunesis Pharmaceuticals Reports Third Quarter 2014 Financial Results and Recent Highlights 7:02 a.m. Nov. 10, 2014 - GlobeNewswire
Sunesis to Host Conference Call on November 10th to Discuss Third Quarter 2014 Financial Results and Recent Highlights 7:01 a.m. Nov. 3, 2014 - GlobeNewswire
Pre-market Biotech Picks - Gilead Sciences, MannKind, IsoRay, Orexigen Therapeutics, and Sunesis Pharma 8:00 a.m. Oct. 14, 2014 - PR Newswire - PRF
Sunesis Announces Results From Pivotal Phase 3 VALOR Trial of Vosaroxin and Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia 5:30 a.m. Oct. 6, 2014 - GlobeNewswire
Biotech Stocks Under Review -- Keryx Biopharma, Sangamo BioSciences, Regeneron Pharma, Sunesis Pharma, and Idera Pharma 8:10 a.m. Sept. 9, 2014 - PR Newswire - PRF
Sunesis to Present at the 2014 Morgan Stanley Global Healthcare Conference 6:01 a.m. Sept. 4, 2014 - GlobeNewswire
Sunesis to Present at the 2014 Wedbush Life Sciences Management Access Conference 6:01 a.m. Aug. 6, 2014 - GlobeNewswire
Sunesis Pharmaceuticals Reports Second Quarter 2014 Financial Results and Recent Highlights 6:02 a.m. Aug. 5, 2014 - GlobeNewswire
Sunesis to Host Conference Call on August 5th to Discuss Second Quarter 2014 Financial Results and Recent Highlights 6:01 a.m. July 29, 2014 - GlobeNewswire
Sunesis Pharmaceuticals Announces European Medicines Agency Acceptance of Pediatric Investigation Plan for Qinprezo(TM) (Vosaroxin) for AML 6:00 a.m. July 9, 2014 - GlobeNewswire
Sunesis to Present at the 2014 Wells Fargo Healthcare Conference 6:01 a.m. June 11, 2014 - GlobeNewswire
Sunesis Announces Presentation of Positive Updated Results From Ongoing MD Anderson-Sponsored Trial of Vosaroxin in AML and High-Risk MDS at ASCO 2014 Annual Meeting 6:01 a.m. June 2, 2014 - GlobeNewswire
Sunesis to Present at Upcoming Investor Conferences 6:02 a.m. May 14, 2014 - GlobeNewswire
Sunesis Pharmaceuticals Reports First Quarter 2014 Financial Results and Recent Highlights 6:01 a.m. May 7, 2014 - GlobeNewswire
(0)
(0)Scroll down for more posts ▼